Brachytherapy
Volume 7, Issue 1 , Pages 43-46, January 2008

Systemic iodine 125 activity after GliaSite brachytherapy: Safety considerations

  • Jarrod B. Adkison

      Affiliations

    • Department of Human Oncology, University of Wisconsin, School of Medicine and Public Health, Madison, WI
    • ,
  • Bruce Thomadsen

      Affiliations

    • Department of Human Oncology, University of Wisconsin, School of Medicine and Public Health, Madison, WI
    • Department of Medical Physics, University of Wisconsin, School of Medicine and Public Health, Madison, WI
    • ,
  • Steven P. Howard

      Affiliations

    • Department of Human Oncology, University of Wisconsin, School of Medicine and Public Health, Madison, WI
    • Corresponding Author InformationCorresponding author. Department of Human Oncology, University of Wisconsin, School of Medicine and Public Health, K4/350 CSC, 600 Highland Avenue, Madison, WI 53792. Tel.: +1-608-263-9961; fax: +1-608-263-9167.

Received 2 August 2007; received in revised form 5 November 2007; accepted 19 November 2007. published online 18 January 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1538-4721(07)00277-2

doi:10.1016/j.brachy.2007.11.001

Brachytherapy
Volume 7, Issue 1 , Pages 43-46, January 2008

Article Tools